Related Experiment Video
Updated: Aug 19, 2026

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays
Published on: April 4, 2011
Quantitative nuclear magnetic resonance analysis and characterization of the derivatized Haemophilus influenzae type
Qiuwei Xu1, Jennifer Klees, Jennifer Teyral
1Merck Research Laboratory, Merck & Co., Inc., West Point, PA 19486, USA. qiuwei_xu@merck.com
Insights
A new quantitative nuclear magnetic resonance (NMR) assay precisely characterizes PedvaxHIB, a vaccine preventing Haemophilus influenzae type b (Hib) disease. This validated NMR method offers a reliable alternative to traditional assays for product release and process monitoring.
Area of Science:
- Vaccinology
- Analytical Chemistry
- Biochemistry
Background:
- PedvaxHIB is a crucial pediatric vaccine against Haemophilus influenzae type b (Hib).
- The vaccine's efficacy relies on chemically conjugating Hib capsular polysaccharide to Neisseria meningitidis outer membrane proteins.
- Accurate characterization of the derivatized polysaccharide is essential for vaccine quality control.
Purpose of the Study:
- To present and validate a quantitative Nuclear Magnetic Resonance (NMR) methodology.
- To characterize the derivatized polysaccharide component of PedvaxHIB.
- To establish a reliable and efficient analytical method for vaccine quality assessment.
Main Methods:
- Development of a quantitative NMR assay for derivatized polysaccharide.
- Validation of the NMR assay according to International Council for Harmonisation (ICH) guidelines.
- Assessment of assay precision, accuracy, specificity, ruggedness, and robustness.
Main Results:
- The quantitative NMR assay demonstrated high precision (RSD ≤ 1%) and accuracy.
- The method showed excellent specificity, with no observable matrix interference.
- The assay proved rugged (RSD < 3% for inter-day/inter-operator variability) and robust to environmental changes.
Conclusions:
- The validated quantitative NMR assay is a reliable method for product release and process monitoring of PedvaxHIB.
- This NMR technique offers a more efficient alternative to existing labor-intensive chromatographic and colorimetric methods.
- The established methodology ensures consistent quality and safety of the Hib vaccine.
Abstract:
PedvaxHIB is a pediatric vaccine that protects children from severe disease caused by the gram-negative bacterium Haemophilus influenzae type b (Hib). The vaccine is made by chemically conjugating Hib capsular polysaccharide to the outer membrane protein complex of Neisseria meningitidis. The protein-conjugated vaccine has proven to be extremely effective in preventing invasive Hib disease in infants and young children. This paper presents the nuclear magnetic resonance (NMR) methodology for the quantitative characterization of derivatized polysaccharide and its validation closely following ICH guidelines. The assay has been shown to be precise and accurate (relative standard deviation [RSD]

